Global mRNA Vaccines and mRNA Drugs Supply, Demand and Key Producers, 2023-2029

Global mRNA Vaccines and mRNA Drugs Supply, Demand and Key Producers, 2023-2029

The global mRNA Vaccines and mRNA Drugs market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

This report studies the global mRNA Vaccines and mRNA Drugs production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for mRNA Vaccines and mRNA Drugs, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of mRNA Vaccines and mRNA Drugs that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global mRNA Vaccines and mRNA Drugs total production and demand, 2018-2029, (K Units)

Global mRNA Vaccines and mRNA Drugs total production value, 2018-2029, (USD Million)

Global mRNA Vaccines and mRNA Drugs production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)

Global mRNA Vaccines and mRNA Drugs consumption by region & country, CAGR, 2018-2029 & (K Units)

U.S. VS China: mRNA Vaccines and mRNA Drugs domestic production, consumption, key domestic manufacturers and share

Global mRNA Vaccines and mRNA Drugs production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)

Global mRNA Vaccines and mRNA Drugs production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)

Global mRNA Vaccines and mRNA Drugs production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units).

This reports profiles key players in the global mRNA Vaccines and mRNA Drugs market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Thermo Fisher, Merck, Qiagen N.V., CureVac, In-Cell-Art, eTheRNA, Takara Bio Inc., Sangamo Therapeutics and Roche CustomBiotech, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World mRNA Vaccines and mRNA Drugs market.

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global mRNA Vaccines and mRNA Drugs Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global mRNA Vaccines and mRNA Drugs Market, Segmentation by Type
Vaccine
API

Global mRNA Vaccines and mRNA Drugs Market, Segmentation by Application
Infectious Disease
Cancer

Companies Profiled:
Thermo Fisher
Merck
Qiagen N.V.
CureVac
In-Cell-Art
eTheRNA
Takara Bio Inc.
Sangamo Therapeutics
Roche CustomBiotech
BioNTech
Tiba Biotechnology
TriLink Bio Technologies
Argos Therapeutics
Moderna Therapeutics
NEB
Ethris
Aldevron
Promega
Translate Bio

Key Questions Answered

1. How big is the global mRNA Vaccines and mRNA Drugs market?

2. What is the demand of the global mRNA Vaccines and mRNA Drugs market?

3. What is the year over year growth of the global mRNA Vaccines and mRNA Drugs market?

4. What is the production and production value of the global mRNA Vaccines and mRNA Drugs market?

5. Who are the key producers in the global mRNA Vaccines and mRNA Drugs market?